# OnCo record axl (target). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/targets/axl/>
  a schema:BioChemEntity ;
  onco:kind "target" ;
  schema:identifier "axl" ;
  schema:name "AXL"@en ;
  schema:description "A receptor that helps cancer cells survive stress, resist treatment and spread. Cabozantinib is among the multi-kinase drugs that block it, and dedicated AXL inhibitors and antibody-drug conjugates are in trials."@en ;
  schema:url <https://onco.cc/targets/axl/> ;
  schema:dateModified "2026-09-04"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/AXL_receptor_tyrosine_kinase>, <https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:905>, <https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000167601>, <https://www.uniprot.org/uniprotkb/P30530/entry>, <https://www.ncbi.nlm.nih.gov/gene/558> ;
  schema:citation <https://www.uniprot.org/uniprotkb/P30530/entry> ;
  schema:alternateName "AXL" ;
  onco:targetClass "kinase" ;
  onco:firstDescribed "1990"^^xsd:gYear ;
  onco:cancers <https://onco.cc/cancers/rcc/>, <https://onco.cc/cancers/hcc/>, <https://onco.cc/cancers/thyroid/> ;
  onco:drugs <https://onco.cc/drugs/cabozantinib/> .